Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 14 at 2:00 PM EDT

Register Free →

PROCAINAMIDE HYDROC

Active
SPE2DP-26-T-5314Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Solicitation SPE2DP-26-T-5314 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm for the procurement of Procainamide Hydrochloride Injection, USP. The requirement is for two packages, with each package containing 25 vials of 100 mg/mL, 10 mL (NSN 6505-01-240-8703). The specified product is manufactured by Pfizer Inc under part number NDC00409-1902-01. The item must have a non-extendable shelf life of 24 months, with at least 21 months remaining upon delivery to the government. Delivery is required within five days after receipt of order, with FOB, inspection, and acceptance all occurring at the destination. The contractor must adhere to strict medical packaging and marking standards, specifically Medical Marking Standard No. 1 and 1C, which supersedes MIL-STD-129. Packaging must be commercial, utilizing suitable sealed unit containers and exterior shipping containers to prevent damage. The solicitation incorporates various FAR and DFARS clauses, including requirements for the Buy American and Balance of Payments Program, safeguarding covered defense information, and hazardous material labeling per 29 CFR 1910.1200. Quotes must be submitted via the DLA Internet Bid Board System by October 5, 2026, and must include the bidder's contact information, manufacturer details, and item description. Payment requests and receiving reports are to be processed electronically through the Wide Area WorkFlow system.

General Info

DLA seeks quotes for Pfizer Procainamide Hydrochloride Injection by October 5, 2026.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

USA

Set-Aside

NONE

Documents

1

RFQ SPE2DP-26-T-5314

PDF, High priority: read this first21 pages · rfq
High

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

1 update
PhaseSolicitation
Posted

Solicitation

Notice updated

The notice description changed.

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Office AddressUSA
Contacts

Full Description

Show more
PROCAINAMIDE HYDROC
PROCAINAMIDE HYDROCHLORIDE INJECTION,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
100 MG/ ML,10 ML, VIAL, 25'S
U/I (1) PACKAGE
SHALL HAVE A SHELF LIFE OF 24 MONTHS.
NOT LESS THAN 21 MONTHS SHALL HAVE ELAPSED FROM DATE OF MANUFACTURE TO
DATE OF DELIVERY TO THE GOVERNMENT.
.
SPE2DP-26-T-5314
SECTION B
LABELING AND MARKING MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD
NO. 1C.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
1 PG = 25 EA RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
PFIZER INC 86491 P/N NDC00409-1902-01
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7009199949 0001 PG 2.000
NSN/MATERIAL:6505012408703
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-240-8703 Quantity: 2 PG Purchase Request: 7009199949QTY: 2 Delivery: 5 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
ZINC OXIDE OINTMENT
Solicitation # SPE2DP-27-T-0041
Solicitation SPE2DP-27-T-0041, issued by the DLA Troop Support Medical Supply Chain Pharm FSA, is for the procurement of Zinc Oxide Ointment USP. The required product is a topical skin protectant containing 20% zinc oxide, delivered in 1oz (28.4gm) collapsible tubes. The solicitation consists of two line items: CLIN 0001 for 10 units and CLIN 0002 for 5 units. The items must be stored at controlled room temperature not exceeding 30 degrees Celsius (86 degrees Fahrenheit) and have a non-extendable shelf life of 36 months. Delivery is required within 5 days after order, with an original required delivery date of October 2, 2026. Shipping is FOB Destination, with inspection and acceptance also occurring at the destination. The contractor must use the fastest traceable means for shipping and is prohibited from using Parcel Post. Packaging must comply with RP001 DLA Packaging Requirements and MIL-STD-129, with specific medical marking required per Medical Marking Standard No. 1. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it shall be commercially packaged per ASTM D3951. The contract incorporates various FAR and DFARS clauses, including requirements for combating trafficking in persons, safeguarding covered defense information, and adherence to the Buy American and Balance of Payments Program for quotes above the micro-purchase threshold. Payment and invoicing must be processed electronically through the Wide Area WorkFlow system. This is an FDA-regulated drug or device, and the contracting official must confirm the product specialist's referral in EBS.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 7 days
View Details
NAICS: 325412
New
DIBBS
VECURONIUM BROMIDE FOR
Solicitation # SPE2DP-26-T-5284
Solicitation SPE2DP-26-T-5284, issued by the DLA Troop Support Medical Supply Chain, is for the procurement of Vecuronium Bromide for Injection. The required product is a freeze dried powder containing 10mg of active ingredient, provided in packages of 10 vials. The material must be stored at USP controlled room temperature (20 to 25 degrees Celsius) and protected from light. The total shelf life is 24 months, with a mandatory minimum of 21 months remaining upon receipt by the first government activity. The procurement consists of two line items, each for a quantity of 3 packages, with required delivery dates of September 29 and September 30, 2026. Delivery is FOB Destination to AFMEDCOM CSDC West at Travis AFB, California, and must be shipped via traceable means. Inspection and acceptance will occur at the destination. Packaging must be commercial and compliant with DLA packaging requirements and Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical marking. Contractors are required to use the Wide Area WorkFlow system for invoicing and payment. The solicitation incorporates various federal and defense acquisition regulations, including requirements for safeguarding covered defense information and compliance with the Buy American Act. Quotes must be submitted through the DIBBS system, and offerors are encouraged to provide quantity ranges due to potential demand volatility.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 15 hours ago

DEADLINE

in 2 days
View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS